What Is Drug R&D?

Innovative drugs refer to drugs with independent intellectual property patents. Compared with generic drugs, innovative drugs emphasize novel chemical structures or new therapeutic uses, which have not been reported in previous research literature or patents. With the gradual improvement of the status of intellectual property in China, the research on innovative drugs will bring high profits to enterprises.

Innovative drugs

Innovative drugs start with the discovery of new molecules or compounds in the laboratory, understand their safety and toxic reactions through animal experiments, understand the metabolic processes in animals, the sites of action, and their effects, and then undergo the first human trial and undergo Phase I. Phase II and Phase III clinical trials have been approved by drug regulatory agencies after they have proven safe, effective and quality controllable. After 10 to 15 years, it can cost billions of dollars.

The research on innovative drugs is of great significance for China to build an innovative country. In the national (2006-2020) mid- to long-term national science and technology major project, there is a special "major new drug creation project", the purpose of which is to create a group of drugs that have better treatment effects on major diseases and have independent intellectual property rights, and reduce foreign drug Dependency.